I'm loading slowly.
here are the facts:
4 reputable analysts recommendation between $12-$17
NDA any time now
Market cap less than 200Mil
IV is more effective than tablets
5 Venture capitalist behind it
More drugs in the pipeline at Phase one but important drug.
My last killings AFFY early this year, TSRX and ECYT last two months.
Like you I got into TSRX early at $4.90 last December and I then later discovered CEMP and DRTX while doing researching on TSRX and took positions in both DRTX aqnd CEMP at $7.00. I like all three; I think TSRX may have the best chance to be taken over by perhaps CBST. CEMP may be the best long term due to their diverese programs. DRTX seemed to be the undervalued and forgotten one of the group until today's 42 cent gain. I've sold a lot of my TSRX but I plan to keep core holdings in all three of these stocks for the long term. Another biotech company that I came across which also looks interesting is GTXI which is another company with larger insider holdings at around 68% and a small float of less than 20M shares out of approximately 63M outstanding shares.